<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cholesterol, <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (TG), and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> (apo) B were determined in plasma and in <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> subfractions (<z:chebi fb="1" ids="39027">VLDL</z:chebi>, intermediate-density <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> [IDL], <z:chebi fb="15" ids="39026">LDL</z:chebi>, and <z:chebi fb="17" ids="39025">HDL</z:chebi>) in nonobese <z:mp ids='MP_0002057'>NIDDM</z:mp> subjects, who were classified into well-controlled, fairly controlled, or poorly controlled states with or without macrovascular complications (<z:e sem="disease" ids="C1096293" disease_type="Disease or Syndrome" abbrv="">macroangiopathy</z:e> [MA]) </plain></SENT>
<SENT sid="1" pm="."><plain>The same analyses were also performed on subjects who had <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> (CAD) with stable <z:hpo ids='HP_0001681'>angina pectoris</z:hpo> (SA) or unstable <z:hpo ids='HP_0001681'>angina pectoris</z:hpo> (UA) and <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) with atherothrombotic or <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e>, and <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> obliterans (ASO) </plain></SENT>
<SENT sid="2" pm="."><plain>In nonobese <z:mp ids='MP_0002057'>NIDDM</z:mp> subjects, the number of apoB-containing <z:chebi fb="2" ids="6495">lipoproteins</z:chebi> (<z:chebi fb="1" ids="39027">VLDL</z:chebi>, IDL, and <z:chebi fb="15" ids="39026">LDL</z:chebi>) increased </plain></SENT>
<SENT sid="3" pm="."><plain>This alteration was more prominent in subjects with poorly or fairly controlled disease as well as in subjects with MA, but not in those with well-controlled <z:mp ids='MP_0002057'>NIDDM</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Cholesterol/apoB in <z:chebi fb="15" ids="39026">LDL</z:chebi> decreased in subjects with poorly or fairly controlled <z:mp ids='MP_0002055'>diabetes</z:mp> or with MA and was correlated with <z:hpo ids='HP_0003233'>low HDL cholesterol</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The disorder is characterized by <z:hpo ids='HP_0003141'>hyperbetalipoproteinemia</z:hpo> with elevated <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> and small dense <z:chebi fb="15" ids="39026">LDL</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:mp ids='MP_0001261'>obese</z:mp> <z:mp ids='MP_0002057'>NIDDM</z:mp> subjects, the similar disorder was more pronounced </plain></SENT>
<SENT sid="7" pm="."><plain>Glycemic control had less effect and <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, if present, aggravated the <z:chebi fb="23" ids="18059">lipid</z:chebi> disorder </plain></SENT>
<SENT sid="8" pm="."><plain>In those with CAD, the number of IDLs increased and the <z:chebi fb="15" ids="39026">LDL</z:chebi> fraction had the properties of small dense <z:chebi fb="15" ids="39026">LDL</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> decreased </plain></SENT>
<SENT sid="10" pm="."><plain>In those with UA, the <z:chebi fb="15" ids="39026">LDL</z:chebi> number increased without elevation of <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi>, indicating typical <z:hpo ids='HP_0003141'>hyperbetalipoproteinemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The subjects with atherothrombotic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, an increased number of small-sized <z:chebi fb="15" ids="39026">LDLs</z:chebi> was noted </plain></SENT>
<SENT sid="12" pm="."><plain>In those with ASO, the number of <z:chebi fb="1" ids="39027">VLDL</z:chebi> and IDL increased with small <z:chebi fb="15" ids="39026">LDL</z:chebi> </plain></SENT>
<SENT sid="13" pm="."><plain><z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> decreased in those with CAD, cerebrovascular disease, and ASO </plain></SENT>
<SENT sid="14" pm="."><plain>Since similar quantitative and qualitative alterations of apoB-containing <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> have been observed in <z:mp ids='MP_0002057'>NIDDM</z:mp> patients as well as in those with macrovascular diseases, diabetic patients are thought to be more susceptible to the initiation and progression of atheromatous lesions in coronary, brain, and peripheral arteries </plain></SENT>
</text></document>